SEC
SlamSEC
SearchBrowseEarnings

Lyra Therapeutics, Inc.

Nasdaq:LYRA
Surgical & Medical Instruments & Apparatus·WATERTOWN, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Lyra is a small constellation. It is one of the 48 listed by the 2nd century astronomer Ptolemy, and is one of the modern 88 constellations recognized by the International Astronomical Union.

Revenue
$1.6M
+14.3% YoY
FY 2024
Adj. EBITDA
-$66.8M
-4290.2% margin
FY 2024
Net Income
-$62.7M
-4023.1% margin
FY 2024
EPS (Diluted)
-$1.26
FY 2024
Stock Price
$1.30
+1.7%
2026-03-09
52W Range
$0.91 – $37.50
P/E Ratio
-1.0x
Market Cap
$2.3M
Cash
$22.4M
FY 2024
Total Debt
—
Net Cash
$22.4M
FY 2024
Enterprise Value
-$20.0M
Debt / EBITDA
0.3x
FY 2024
EV / EBITDA
0.3x
Employees
—